• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    (NY: RVTY )

    108.88 -0.92 (-0.84%)
    Streaming Delayed Price Updated: 12:17 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 266,443
    Open 109.99
    Bid (Size) 108.70 (4)
    Ask (Size) 108.88 (2)
    Prev. Close 109.80
    Today's Range 106.92 - 109.99
    52wk Range 79.50 - 131.96
    Shares Outstanding N/A
    Dividend Yield 0.26%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Revvity To Hold Earnings Call on Monday, July 29, 2024
    From Revvity
    Via Business Wire
    Revvity to Present at Goldman Sachs Global Healthcare Conference
    From Revvity
    Via Business Wire

    Performance

    YTD
    -1.40%
    -1.40%
    1 Month
    +1.48%
    +1.48%
    3 Month
    +9.56%
    +9.56%
    6 Month
    +2.79%
    +2.79%
    1 Year
    -13.95%
    -13.95%

    More News

    Read More
    4 Analysts Have This To Say About Revvity
    Via Benzinga
    RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Earnings Preview For Revvity
    Via Benzinga
    The Latest Analyst Ratings For Revvity
    Via Benzinga
    Peeling Back The Layers: Exploring Revvity Through Analyst Insights
    Via Benzinga
    US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
    Via Benzinga
    Revvity Announces Financial Results for the First Quarter of 2024
    From Revvity
    Via Business Wire
    Revvity Board Declares Quarterly Dividend
    From Revvity
    Via Business Wire
    Revvity to Present at BofA Securities 2024 Health Care Conference
    From Revvity
    Via Business Wire
    Enphase Energy Reports Weak Results, Joins Lithia Motors And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Revvity Unveils a New Era of Automated Tuberculosis Testing
    From Revvity
    Via Business Wire
    Revvity To Hold Earnings Call on Monday, April 29, 2024
    From Revvity
    Via Business Wire
    Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
    From Revvity
    Via Business Wire
    Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
    From Revvity
    Via Business Wire
    Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
    From Revvity
    Via Business Wire
    Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
    From Revvity
    Via Business Wire
    Revvity to Present at Upcoming Investor Conferences
    From Revvity
    Via Business Wire
    Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
    From Revvity
    Via Business Wire
    Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
    From Revvity
    Via Business Wire
    Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors
    From Revvity
    Via Business Wire
    Earnings Scheduled For February 1, 2024
    Via Benzinga
    Revvity Board Declares Quarterly Dividend
    From Revvity
    Via Business Wire
    Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance
    From Revvity
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.